The Receptor Tyrosine Kinase TrkA Is Increased and Targetable in HER2-Positive Breast Cancer

The tyrosine kinase receptor A (NTRK1/TrkA) is increasingly regarded as a therapeutic target in oncology. In breast cancer, TrkA contributes to metastasis but the clinicopathological significance remains unclear. In this study, TrkA expression was assessed via immunohistochemistry of 158 invasive du...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomolecules
Главные авторы: Griffin, Nathan, Marsland, Mark, Roselli, Severine, Oldmeadow, Christopher, Attia, John, Walker, Marjorie M., Hondermarck, Hubert, Faulkner, Sam
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7564775/
https://ncbi.nlm.nih.gov/pubmed/32957504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10091329
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы